Transplantation of a tissue-engineered pulmonary artery.

By T. Shin’oka, Y. Imai, Y. Ikada. New England Journal of Medicine, 2001

623 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Biomaterial technology for tissue engineering applications (2009, background): “To prepare pulmonary vein and bone substitutes for human treatment, the cells of blood vessel and bone marrow-derived stem cells are cultured in the porous scaffolds of tube-shape polylactide (Shin’oka et al. 2001) and cubic hydroxyl apatite (Ohgushi & Caplan 1999).”
Scaffold-Free Vascular Tissue Engineering Using Bioprinting (2009, background): “Therefore it is not surprising that the first clinical applications of tissueengineered vascular grafts have either targeted low-pressure applications [4] or relied on an entirely scaffold-free method termed sheet-based tissue-engineering [15–18] (currently under study also for myocardial reconstruc”
Challenges in tissue engineering (2006, background): “2004), vascular conduits for extracardiac Fontan operation (Shin’oka et al. 2001; Naito et al. 2003; Matsumura et al. 2003) and peripheral nerve (Weber et al.”